A photo of William Brinkman.

William B. Brinkman, MD, MEd, MSc

  • Director, Division of General and Community Pediatrics, Carl Weihl Professor of Pediatrics
  • Member, Center for ADHD
  • Member, Center for Innovation in Chronic Disease Care
  • Professor, UC Department of Pediatrics
I enjoy getting to know what is most important to patients and families when choosing treatment options.



My path to becoming a pediatrician started when I had medical problems at age 10. Seeing the impact doctors had on my entire family inspired me to pursue a career in medicine.

I practice primary care pediatrics, and I enjoy getting to know what is most important to patients and families when choosing treatment options. My own experiences as a patient showed me the importance of effective communication, especially when multiple medically reasonable options may differ in meaningful ways.

In addition to practicing medicine and conducting research, I serve as the Carl Weihl Professor of Pediatrics and director of the Division of General & Community Pediatrics at Cincinnati Children’s. In these roles, I have the privilege of leading a diverse, talented, multidisciplinary team who share a passion and commitment to transform primary care delivery and improve population health. We seek to do this through exceptional clinical programs, high-impact clinical and translational research, innovative educational programs, and effective academic and community partnerships.

In my research, I’m looking for ways to make it easier for children and parents to achieve their goals in partnership with their healthcare providers.

When I’m not at work, I enjoy spending time with my wife and two children.


Predictors of Stimulant Medication Continuity in Children with Attention-Deficit/Hyperactivity Disorder. Kamimura-Nishimura, K; Brinkman, W; Epstein, J; Zhang, Y; Altaye, M; Froehlich, T. Journal of Developmental and Behavioral Pediatrics. 2022; 43:311-319.

Decision making about anti-TNF therapy: A pilot trial of a shared decision-making intervention. Lipstein, EA; Brinkman, WB; Zhang, Y; Hommel, KA; Ittenbach, RF; Liu, C; Denson, LA. Patient Education and Counseling. 2022; 105:1075-1081.

An Immersive Virtual Reality Curriculum for Pediatric Hematology Clinicians on Shared Decision-making for Hydroxyurea in Sickle Cell Anemia. Real, FJ; Hood, AM; Davis, D; Cruse, B; Klein, M; Johnson, Y; McTate, E; Brinkman, WB; Hackworth, R; Hackworth, K; et al. Journal of Pediatric Hematology/Oncology. 2022; 44:e799-e803.

Resolving Pediatric Preventive Care Gaps Through Hospital Inreach. Morehous, JF; White, C; Brinkman, WB; DeBlasio, DJ; Reyner, A; Kleiman, J; Iyer, SB. Pediatrics. 2022; 149.

Integrating shared decision making into trial consent: A nested, cluster-randomized trial. Lipstein, EA; Breslin, M; Dodds, CM; Kappelman, MD; Ollberding, NJ; Margolis, P; Xu, Y; Brinkman, WB. Patient Education and Counseling. 2021; 104:1575-1582.

Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial. Hood, AM; Strong, H; Nwankwo, C; Johnson, Y; Peugh, J; Mara, CA; Shook, LM; Brinkman, WB; Real, FJ; Klein, MD; et al. JMIR Research Protocols. 2021; 10.

Development and Acceptability of a Patient Decision Aid for Pain Management in Juvenile Idiopathic Arthritis: The JIA Option Map. Toupin-April, K; Huber, AM; Duffy, CM; Proulx, L; Morgan, EM; Cohen, JS; Gaboury, I; Li, LC; Tugwell, P; Stinson, J; et al. Patient. 2020; 13:719-728.

Addressing Recruitment Challenges in the Engage-HU Trial in Young Children with Sickle Cell Disease. Hood, AM; Strong, H; Nwankwo, C; Johnson, Y; Mara, CA; Shook, LM; Brinkman, W; Real, FJ; Klein, M; King, AA; et al. Blood. 2020; 136:26-27.

Comparison of Performance on ADHD Quality of Care Indicators: Practitioner Self-Report Versus Chart Review. Gordon, MK; Baum, RA; Gardner, W; Kelleher, KJ; Langberg, JM; Brinkman, WB; Epstein, JN. Journal of Attention Disorders. 2020; 24:1457-1461.

Pre-Existing Comorbid Emotional Symptoms Moderate Short-Term Methylphenidate Adverse Effects in a Randomized Trial of Children with Attention-Deficit/Hyperactivity Disorder. Froehlich, TE; Brinkman, WB; Peugh, JL; Piedra, AN; Vitucci, DJ; Epstein, JN. Journal of Child and Adolescent Psychopharmacology. 2020; 30:137-147.

From the Blog

Patient Portal Messaging Can Help Practices Catch Up with Well-Child Visits
Community Health

Patient Portal Messaging Can Help Practices Catch Up with Well-Child Visits

William B. Brinkman, MD, MEd, MSc11/18/2022

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey